Enhanced drug delivery in transdermal systems

Details for Australian Patent Application No. 2002320038 (hide)

Owner Noven Pharmaceuticals, Inc.

Inventors Houze, David; Nguyen, Viet

Agent Davies Collison Cave

Pub. Number AU-B-2002320038

PCT Number PCT/US02/16579

PCT Pub. Number WO2002/102390

Priority 60/298,381 18.06.01 US; 09/948,107 07.09.01 US

Filing date 18 June 2002

Wipo publication date 2 January 2003

Acceptance publication date 5 July 2007

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/5685 (2006.01)

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/298,381 18.06.01 US; 09/948,107 07.09.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002320038

5 July 2007 Application Accepted

  Published as AU-B-2002320038

1 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002320039-METHODS FOR THE IDENTIFICATION OF INHIBITORS OF PECTIN ESTERASE EXPRESSION OR ACTIVITY IN PLANTS

2002320037-COMPOSITIONS COMPRISING A CATIONIC HOMOPOLYMER AND THEIR USE FOR STABILIZATION OF AN OXIDIZING SOLUTION